With activist investor Starboard Value holding a seat on Kenvue’s board of directors, the consumer healthcare company is taking big steps in its strategic review that has now resulted in a leadersh | Along with the CEO transition announcement,

Kenvue shares (KVUE) are in focus Monday after the consumer health firm ousted its CEO, Thibaut Mongon, and announced a strategic review aimed at optimizing the portfolio. Kirk Perry will be the interim chief executive as the company searches for a permanent replacement,

All that culminated on Monday with the abrupt resignation of Kenvue CEO Thibaut Mongon, his replacement by board director Kirk Perry on an interim basis, and the confirmation that Kenvue is undertaking a strategic review in the hopes of “optimizing” a sprawling portfolio and boosting profitability.

Por MICHELLE CHAPMANEl CEO de Kenvue dejará su cargo mientras el fabricante de las marcas Listerine y Band-Aid continúa con una revisión estratégica de sus negocios. Thibaut